Related Experiment Video
Updated: Jun 3, 2026
06:33
Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published on: November 10, 2023
[Research Progress on the Bone Marrow Microenvironment in Beta-Thalassemia --Review]
Xin Peng1, Ya-Jie Wang2, Zeng-Zheng Li2
1Department of Pediatrics, The 2nd Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 2, 2026
Summary
Beta-thalassemia, a common genetic blood disorder, damages the bone marrow microenvironment through iron overload and ineffective red blood cell production. Correcting this microenvironment is crucial for effective thalassemia treatment.
Area of Science:
- Hematology
- Genetics
- Cell Biology
Background:
- Thalassemia is a prevalent single-gene recessive disorder affecting hemoglobin production.
- Beta-thalassemia involves defects in beta-globin synthesis, leading to alpha-beta globin chain imbalance.
- This imbalance causes iron overload and ineffective erythropoiesis, damaging the bone marrow microenvironment.
Purpose of the Study:
- To review the mechanisms of bone marrow microenvironment destruction in beta-thalassemia.
- To explore therapeutic strategies for improving the bone marrow microenvironment.
- To discuss the role of stem cell transplantation in managing beta-thalassemia.
Main Methods:
- Literature review of studies on beta-thalassemia and bone marrow microenvironment.
- Analysis of research on iron overload and ineffective erythropoiesis.
- Synthesis of data on mesenchymal stem cells, osteoblasts, and osteoclasts in thalassemia.
Main Results:
- Beta-thalassemia significantly alters the bone marrow microenvironment.
- Iron overload and ineffective erythropoiesis are key contributors to microenvironment destruction.
- Changes in bone marrow cells exacerbate hematopoietic system damage.
Conclusions:
- Restoration of the bone marrow microenvironment is essential for treating beta-thalassemia.
- Targeting microenvironmental defects offers promising therapeutic avenues.
- Stem cell transplantation shows potential for comprehensive treatment.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
10:03Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
Published on: August 1, 2017
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:20Overview of Hematopoiesis
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...